Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

Presentation TCT 2018

Case #2: A Case of Coronary Obstruction After TAVR

Presenter: Samir R. Kapadia, Bernard Prendergast, Eric Eeckhout, Ganesh Manoharan, John C. Messenger, Bernhard Reimers, Paul Sorajja, Eric Vang

September 23, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke

September 22, 2018

Presentation TCT 2018

Controlled Flow Infusion: A New Approach to Measure Dynamic Microvascular Resistance and to Treat Microvascular Obstruction in Acute Heart Attack Patients in the Cath Lab: CorFlowTherapeutics AG

Presenter: Louis A. Cannon, Juan F. Granada, Jon H Hoem

September 22, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Presentation TCT 2018

TCT-23: Derivation and Validation of Temperature Recovery Time as an Invasive Predictor of Microvascular Obstruction and Prognosis After ST-Segment Elevation Myocardial Infarction

Presenter: Angeles Alonso Garcia, Rajesh M. Dave, Annette Maznyczka

September 21, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

Presenter: Omar Khalique

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Presenter: Azeem Latib

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Presenter: Ariel Finkelstein

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR

Presenter: Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Incidence, Predictors, and Consequences of New LBBB and New Permanent Pacemakers After TAVR

Presenter: Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

When and How to Use Transcatheter Devices for PVL Closure After TAVR

Presenter: Colin M. Barker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Expert Commentary: PVL Assessment and Management When to Postdilate

Presenter: Rebecca T. Hahn

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Advertisement

Top News in Coronary Artery Disease: 2018

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Case #2: A Case of Coronary Obstruction After TAVR

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Controlled Flow Infusion: A New Approach to Measure Dynamic Microvascular Resistance and to Treat Microvascular Obstruction in Acute Heart Attack Patients in the Cath Lab: CorFlowTherapeutics AG

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

TCT-23: Derivation and Validation of Temperature Recovery Time as an Invasive Predictor of Microvascular Obstruction and Prognosis After ST-Segment Elevation Myocardial Infarction

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Cases of Unusual Mechanisms of Coronary Occlusion During TAVR

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines

Techniques to Reduce the Frequency of Pacemaker Implantation After TAVR

Incidence, Predictors, and Consequences of New LBBB and New Permanent Pacemakers After TAVR

When and How to Use Transcatheter Devices for PVL Closure After TAVR

Expert Commentary: PVL Assessment and Management When to Postdilate

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content